Stem cell pharmacogenomics

Current Topics in Medicinal Chemistry

Volumn 4, Issue 13, 2004, Pages 1371-1383

  Bapat, S A ^a   Mishra, G C ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

Host factors; Immunosuppressive; Pharmacogenomics; Stem cell reprogramming; Stem cell therapy; Target genes

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; COMPLEMENTARY DNA; DYSTROPHIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

BIOINFORMATICS; CELL DIFFERENTIATION; CELL RENEWAL; DEGENERATIVE DISEASE; DRUG MECHANISM; DUCHENNE MUSCULAR DYSTROPHY; EXPRESSED SEQUENCE TAG; GENE TARGETING; GENETIC DISORDER; GENOMICS; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; INDIVIDUALIZATION; MEDICAL RESEARCH; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHARMACOGENOMICS; PROTEOMICS; QUALITY OF LIFE; REVIEW; STEM CELL TRANSPLANTATION; TREATMENT PLANNING; UMBILICAL CORD BLOOD;

EID: 4544241008     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568026043387674     Document Type: Review

References (89)

1. Lemischka, I. Stem cell dogmas in the genomics era. Rev. Clin. Exp. Hematol. 2001, 5, 15-25.
2. Nebert, D.W. and Bingham, E. Pharmacogenomics: out of the lab and into the community. Trends in Biotech. 2001, 19, 519 - 523.
3. Kulkarni, S.K. On the safety of nimesulide a preferential COX - 2 inhibitor. Current Science 2002, 83, 1442-1443.
4. Wride, M.A., Mansergh, F.C., Somani, J.M., Winkfein, R.J., Rancourt, D.E. Characterization and in silico mapping of a novel murine zinc finger transcription factor. Gene 2002, 289, 49-59.
5. Miyazato, A., Ueno, S., Ohmine, K., Ueda, M., Yoshida, K., Yamashita, Y., Kaneko, T., Mori, M., Kirito, K., Toshima, M., Nakamura, Y., Saito, K., Kano, Y., Furusawa, S., Ozawa, K., Mano, H. Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction. Blood 2001, 98, 422-7.
6. Candeliere, G.A., Rao, Y., Floh, A., Sandler, S.D., Aubin, J.E. cDNA fingerprinting of osteoprogenitor cells to isolate differentiation stage-specific genes Nucleic Acids Res. 1999, 27, 1079-83.
7. Zhang, Q.H., Ye, M., Wu, X.Y., Ren, S.X., Zhao, M., Zhao, C.J., Fu, G., Shen, Y., Fan, H.Y., Lu, G., Zhong, M., Xu, X.R., Han, Z.G., Zhang, J.W., Tao, J., Huang, Q.H., Zhou, J., Hu, G.X., Go, J., Chen, S.J., Chen, Z. Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cells. Genome Res. 2000, 10, 1546-60.
8. Scimeca, J.C., Quincey, D., Parrinello, H., Romatet, D., Grosgeorge, J., Gaudray, P., Philip, N., Fischer, A., Carle, G.F. Novel mutations in the TCIRG1 gene encoding the a3 subunit of the vacuolar proton pump in patients affected by infantile malignant osteopetrosis Hum. Mutat. 2003, 21, 151-7.
9. Campos-Xavier, A.B., Saraiva, J.M., Ribeiro, L.M., Munnich, A., Cormier-Daire, V. Chloride channel 7 (CLCN7) gene mutations in intermediate autosomal recessive osteopetrosis. Hum. Genet. 2003, 112, 186-9.
10. Hamdane, M., Smet, C., Sambo, A.V., Leroy, A., Wieruszeski, J.M., Delobel, P., Maurage, C.A., Ghestem, A., Wintjens, R., Begard, S., Sergeant, N., Delacourte, A., Horvath, D., Landrieu, I., Lippens, G., Buee, L. Pin1: a therapeutic target in Alzheimer neurodegeneration. J. Mol. Neurosci. 2002, 19, 275-87
11. Siest, G., Bertrand, P., Herbeth, B., Vincent-Viry, M., Schiele, F., Sass, C., Visvikis, S. Centre de Medecine Preventive, Universite Henri Poincare Nancy I. Apolipoprotein E polymorphisms and concentration in chronic diseases and drug responses. Clin. Chem. Lab. Med. 2000, 38, 841-52
12. Gibson, G.E., Huang, H.M. Oxidative processes in the brain and non-neuronal tissues as biomarkers of Alzheimer's disease. Front Biosci. 2002, 7, 1007-15.
13. Ende, N., Chen, R., Ende-Harris, D. Human umbilical cord blood cells ameliorate Alzheimer's disease in transgenic mice. J. Med. 2001, 32, 241-7
14. Pierce, E.A., Liu, Q., Igoucheva, O., Omarrudin, R., Ma, H., Diamond, S.L., Yoon, K. Oligonucleotide-directed single-base DNA alterations in mouse embryonic stem cells. Gene Ther. 2003, 10, 24-33.
15. Becker, P.S. Hematopoietic stem cell gene therapy for inherited bone marrow disorders: past accomplishments and continued challenges. J. Cell Biochem. Suppl. 2002, 38, 55-64.
16. Macdonald, D., Reiter, A., Cross, N.C. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1. Acta. Haemato. 2002, 107, 101-7.
17. Heim, D.A., Dunbar, C.E. Hematopoietic stem cell gene therapy: towards clinically significant gene transfer efficiency Immunol. Rev. 2000, 178, 29-38.
18. Temple, S. The development of neural stem cells. Nature 2001, 414, 112-117.
19. Smith, A. 2001, In: Stem Cell Biology , Cold Spring Harbour laboratory Press.
20. Cao, Q.L., Howard, R.M., Dennison, J.B., Whittemore, S.R. Differentiation of engrafted neuronal-restricted precursor cells is inhibited in the traumatically injured spinal cord. Exp. Neurol. 2002, 177, 349-59.
21. Down, J.D. White-Scharf, M.E. Reprogramming immune responses: enabling cellular therapies and regenerative medicine. Stem Cells 2003, 21, 21-32.
22. Hackney, J.A., Charbord, P., Brunk, B.P., Stoeckert, C.J., Lemischka, I.R. Moore, K.A. A molecular profile of a hematopoietic stem cell niche. Proc. Natl. Acad. Sci. USA, 2002 99, 13061-13066.
23. Sullivan, K.M. Furst, D.E. The evolving role of blood and marrow transplantation for the treatment of autoimmune diseases. J. Rheumatol. Suppl. 1997, 48, 46-52.
24. Englund, U., Bjorklund, A., Wictorin, K., Lindvall, O., Kokaia, M. Grafted neural stem cells develop into functional pyramidal neurons and integrate into host cortical circuitry. Proc. Natl. Acad. Sci. USA 2002, 99, 17089-94.
25. Puri, P.L., Bhakta, K., Wood, L.D., Costanzo, A., Zhu, J., Wang, J.Y. A myogenic differentiation checkpoint activated by genotoxic stress. Nat. Genet. 2002, 32, 585-93.
26. Zheng, L., Flesken-Nikitin, A., Chen, P.L., Lee, W.H. Deficiency of Retinoblastoma gene in mouse embryonic stem cells leads to genetic instability. Cancer Res. 2002, 62, 2498-502.
27. Huang, S., Law, P., Francis, K., Palsson, B.O., Ho, A.D. Symmetry of initial cell divisions among primitive hematopoietic progenitors is independent of ontogenic age and regulatory molecules. Blood 1999, 94, 2595-604.
28. Holt, S.E., Wright, W.E. and Shay, J.W. Regulation of telomerase activity in immortal cell lines. Mol. Cell Biol. 1996, 16, 2932-2939.
29. Goto, S., Lin, Y.C., Lai, C.Y., Lee, C.M., Pan, T.L., Lord, R., Chiang, K.C., Tseng, H.P., Lin, C.L., Cheng, Y.F., Yokoyama, H., Kitano, S., Chen, C.L. Telomerase activity in rat liver allografts. Transplantation 2000, 69, 1013-5.
30. Murasawa, S., Llevadot, J., Silver, M., Isner, J.M., Losordo, D.W., Asahara, T. Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation 2002, 106, 1133-9.
31. Shi, S., Gronthos, S., Chen, S., Reddi, A., Counter, C.M., Robey, P.G., Wang, C.Y. Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression. Nat. Biotechnol. 2002, 20, 587-91.
32. Jiang, X.R., Jimenez, G., Chang, E. et al. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat. Genet. 1999, 21, 111-114.
33. Morales, C.P., Holt, S.E., Ouellette, M. et al. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat. Genet. 1999, 21, 115-118.
34. Rufer, N., Migliaccio, M., Antonchuk, J. et al. Transfer of the human telomerase reverse transcriptase (TERT) gene into T lymphocytes results in extension of replicative potential. Blood 2001, 98, 597-603
35. Fareed MU, Moolten FL. Suicide gene transduction sensitizes murine embryonic and human mesenchymal stem cells to ablation on demand - a fail-safe protection against cellular misbehavior. Gene Ther. 2002, 9, 955-62.
36. Plumb, J.A., Bilsland, A., Kakani, R., Zhao, J., Glasspool, R.M., Knox, R.J., Evans, T.R., Keith, W.N. Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954. Oncogene 2001, 20, 7797-803.
37. Majumdar, A.S., Hughes, D.E., Lichtsteiner, S.P., Wang, Z., Lebkowski, J.S., Vasserot, A.P. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters. Gene Ther. 2001, 8, 568-78.
38. Spradling, A., Drummond-Barbosa, D. Kai, T. Stem cells find their niche. Nature 2001, 414, 98 - 104.
39. Dunnett, S.B. Bjorklund, A. 1994 Mechanisms of function of neural grafts in the injured brain In : Functional Neural Transplantation, 531 - 567, Raven Press, New York.
40. Gurevitch, O., Prigozhina, T.B., Pugatsch, T., Slavin, S. Transplantation of allogeneic or xenogeneic bone marrow within the donor stromal microenvironment Transplantation 1999, 68, 1362-8.
41. Moore, M.A. Cytokine and chemokine networks influencing stem cell proliferation, differentiation, and marrow homing. Cell Biochem. Suppl. 2002; 38, 29-38.
42. Wright, D.E., Bowman, E.P., Wagers, A.J., Butcher, E.C. Weissman, I.L. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. The Journal of Experimental Medicine 2002, 195, 1145-1154.
43. Park, K.I., Ourednik, J., Ourednik, V., Taylor, R.M., Aboody, K.S., Auguste, K.I., Lachyankar, M.B., Redmond, D.E., Snyder, E.Y. Global gene and cell replacement strategies via stem cells Gene Ther. 2002, 9, 613-24.
44. Brent L. A history of transplantation immunology Brent L [ed]. Academic, San Diego, 1997.
45. McLaren, F.H., Goncalves, R.M., Menier, C., Dausset, J. Carosella, E.D. J. Neuroimmunol. 2001, 140, 4157 - 4159.
46. Drukker, M., Katz, G., Urbach, A., Schuldiner, M., Markel, G., Itskovitz-Eldor, J., Rubinoff, B., Mandelboim, O. Benvenisty, N. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc. Natl. Acad. Sci. USA 2002, 99, 9864-9869.
47. Fandrich, F., Dresske, B., Bader, M., Schulze, M. Embryonic stem cells share immune-privileged features relevant for tolerance induction. J. Mol. Med. 2002, 80, 343-50.
48. Sayegh, M.H. Turka, L.A. The role of T-cell costimulatory activation pathways in transplant rejection. N. Engl. J. Med. 1998, 338, 1813 - 1821.
49. Wekerle, T., Sayegh, M.H., Hill, J., Zhao, Y., Chandraker, A., Swenson, K.G., Zhao, G., Sykes, M. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance J. Exp. Med. 1998, 187, 2037-44.
50. Seung, E., Iwakoshi, N., Woda, B.A., Markees, T.G., Mordes, J.P., Rossini, A.A., Greiner, D.L. Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice. Blood 2000, 95, 2175-82.
51. Buhler, L., Awwad, M., Basker, M., Gojo, S., Watts, A., Treter, S., Nash, K., Oravec, G., Chang, Q., Thall, A., Down, J.D., Sykes, M., Andrews, D., Sackstein, R., White-Scharf, M.E., Sachs, D.H., Cooper, D.K. High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response. Transplantation 2000, 69, 2296-304.
52. Pizzolato, M.C., Fodor, W.L. An engineered bifunctional recombinant molecule that regulates humoral and cellular effector functions of the immune system. Transplantation 2003, 75, 542-9.
53. Qian, Y., Hamrah, P., Boisgerault, F., Yamagami, S., Vora, S., Benichou, G., Dana, M.R. Mechanisms of Immunotherapeutic Intervention by Anti-CD154 (CD40L) Antibody in High-Risk Corneal Transplantation. J. Interferon Cytokine Res. 2002; 22, 1217-25.
54. Wekerle, T., Kurtz, J., Ito, H., Ronquillo, J.V., Dong, V., Zhao, G., Shaffer, J., Sayegh, M.H., Sykes, M. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat. Med. 2000, 6, 464-469.
55. Awaya, N., Rupert, K., Bryant, E. Failure of adult marrow-derived stem cells to generate marrow stroma after successful hematopoietic stem cell transplantation. Torok-Storb B. Exp. Hematol. 2002, 30, 937-42.
56. Fandrich, F., Lin, X., Chai, G.X., Schulze, M., Ganten, D., Bader, M., Holle, J., Huang, D.-S., Parwaresch, D., Zavazava Nand Binas, B. Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nat. Med. 2002, 8, 171-178.
57. Sykes, M. Mixed chimerism and transplant tolerance. Immunity 2001, 14, 417-424.
58. Danesi, R., Mosca, M., Boggi, U., Mosca, F., Del Tacca, M. Genetics of drug response to immunosuppressive treatment and prospects for personalized therapy Mol. Med. Today 2000, 6, 475-82.
59. Jorgensen, K.A., Koefoed-Nielsen, P.B., Karamperis, N. Calcineurin phosphatase activity and immunosuppression. A review on the role of calcineurin phosphatase activity and the immunosuppressive effect of cyclosporin A and tacrolimus. Scand J. Immunol. 2003, 57, 93-8
60. Dumont, F.J. FK506, an immunosuppressant targeting calcineurin function. Curr. Med. Chem. 2000, 7, 731-48
61. Marton, M.J., DeRisi, J.L., Bennett, H.A., Iyer, V.R., Meyer, M.R., Roberts, C.J., Stoughton, R., Burchard, J., Slade, D., Dai, H., Bassett, D.E. Jr, Hartwell, L.H., Brown, P.O., Friend, S.H. Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat. Med. 1998, 4, 1293-301
62. Lawrence, M.C., Bhatt, H.S., Watterson, J.M., Easom, R.A. Regulation of insulin gene transcription by a Ca(2+)-responsive pathway involving calcineurin and nuclear factor of activated T cells. Mol. Endocrinol. 2001, 15, 1758-67
63. Van Duijnhoven, E.M., Boots, J.M., Christiaans, M.H., Van Hooff, J.P. Metabolic aspects of tacrolimus in renal trans-plantation. Consequences for the choice of an immunosuppressive regimen and for the management of post-transplant diabetes mellitus. Minerva Urol. Nefrol. 2003, 55, 33-42.
64. Lawrence, M.C., Bhatt, H.S., Watterson, J.M., Easom, R.A. Regulation of insulin gene transcription by a Ca(2+)-responsive pathway involving calcineurin and nuclear factor of activated T cells. Mol. Endocrinol. 2001, 15, 1758-6
65. Kochi, S., Takanaga, H., Matsuo, H., Naito, M., Tsuruo, T., Sawada, Y. Effect of cyclosporin A or tacrolimus on the function of blood-brain barrier cells Eur. J. Pharmacol. 1999, 372, 287-95
66. Satoh, T., Munakata, H., Fujita, K., Itoh, S., Itoli, S., Kamataki, T., Yoshizawa, I. Studies on the interactions between drug and estrogen. II. On the inhibitory effect of 29 drugs reported to induce gynecomastia on the oxidation of estradiol at C-2 or C-17 Biol. Pharm. Bull. 2003, 26, 695-700
67. Dobrolet, N.C., Webber, S.A., Blatt, J., Michaels, M., Kiaffas, M., Kurland, G., Boyle, G.J. Hematologic abnormalities in children and young adults receiving tacrolimus-based immunosuppression following cardiothoracic transplantation. Pediatr. Transplant 2001;5:125-31
68. Shihab, F.S., Bennett, W.M., Tanner, A.M., Andoh, T.F. Mechanism of fibrosis in experimental tacrolimus nephrotoxicity, Transplantation 1997, 64, 1829-1837
69. Yamauchi, A., Ieiri, I., Kataoka, Y., Tanabe, M., Nishizaki, T., Oishi, R., Higuchi, S., Otsubo, K., Sugimachi, K. Neurotoxicity induced by tacrolimus after liver transplantation: relation to genetic polymorphisms of the ABCB1 (MDR1) gene Transplantation 2002, 27, 571-2
70. Benet, L.Z., Izumi, T., Zhang, Y., Silverman, J.A., Wacher, V.J. Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery J. Control Release 1999, 62, 25-31
71. Charron, P. and Komajda, M. Genes and their polymorphisms in mono- and multifactorial cardiomyopathies: towards pharmacogenomics in heart failure. Pharmacogenomics 2002, 3, 367-78.
72. Daly, A.K., Day, C.P., Donaldson, P.T. Polymorphisms in immunoregulatory genes: towards individualized immunosuppressive therapy? Am. J. Pharmacogenomics 2002, 2, 13-23.
73. Lai, P.S., Takeshima, Y., Adachi, K., Van Tran, K., Nguyen, H.T., Low, P.S., Matsuo, M., Comparative study on deletions of the dystrophin gene in three Asian populations. J. Hum. Genet. 2002; 47, 552-5.
74. Huard, C., Moisset, P.A., Dicaire, A., Merly, F., Tardif, F., Asselin, I., Tremblay, J.P., Transplantation of dermal fibroblasts expressing MyoD1 in mouse muscles, Biochem. Biophys. Res. Commun. 1998, 248, 648-54.
75. Corti, S., Strazzer, S., Del Bo, R., Salani, S., Bossolasco, P., Fortunato, F., Locatelli, F., Soligo, D., Moggio, M., Ciscato, P., Prelle, A., Borsotti, C., Bresolin, N., Scarlato, G., Comi, G.P. A subpopulation of murine bone marrow cells fully differentiates along the myogenic pathway and participates in muscle repair in the mdx dystrophic mouse Exp. Cell Res. 2002, 277, 74-85.
76. Fukada, S., Miyagoe-Suzuki, Y., Tsukihara, H., Yuasa, K., Higuchi, S., Ono, S., Tsujikawa, K., Takeda, S., Yamamoto, H., Muscle regeneration by reconstitution with bone marrow or fetal liver cells from green fluorescent protein-gene transgenic mice J. Cell Sci. 2002, 115, 1285-93.
77. Gussoni, E., Bennett, R.R., Muskiewicz, K.R., Meyerrose, T., Nolta, J.A., Gilgoff, I., Stein, J., Chan, Y.M., Lidov, H.G., Bonnemann, C.G., Von Moers, A., Morris, G.E., Den Donnen, J.T., Chamberlain, J.S., Kunkel, L.M., Weinberg, K., Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation J. Clin. Invest. 2002, 110, 807-14.
78. Gussoni, E., Blau, H.M., Kunkel, L.M. The fate of individual myoblasts after transplantation into muscles of DMD patients Nat. Med. 1997, 3, 970-7.
79. Aartsma-Rus, A., Bremmer-Bout, M., Janson, A.A., den Dunnen, J.T., van Ommen, G.J., van Deutekom, J.C., Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy, Neuromuscul. Disord. 2002, 12 Suppl 1, S71-7.
80. De Angelis, F.G., Sthandier, O., Berarducci, B., Toso, S., Galluzzi, G., Ricci, E., Cossu, G., Bozzoni, I. Chimeric snRNA molecules carrying antisense sequences against the splice junctions of exon 51 of tile dystrophin pre-mRNA induce exon skipping and restoration of a dystrophin synthesis in Delta 48-50 DMD cells. Proc. Natl. Acad. Sci. USA 2002, 99, 9456-61.
81. Kang, E., Giri, N., Wu, T., Sellers, S., Kirby, M., Hanazono, Y., Tisdale, J., Dunbar, C.E. In vivo persistence of retrovirally transduced murine long-term repopulating cells is not limited by expression of foreign gene products in the fully or minimally myeloablated setting. Hum. Gene. Ther. 2001, 12, 1663-72.
82. Donovan, P.J. and Gearhart, J. The end of the beginning for pluripotent stem cells. Nature, 2001, 414, 92-97.
83. Buhler, L., Kurilla-Mahon, B., Chang, Q., Abraham, S., Alwayn, I.P., Appel, J.Z. 3rd, Newman, D., Awwad, M., White-Scharf, M.E., Sackstein, R., Sachs, D.H, Cooper, D.K., Down, J.D. Cryopreservation and mycophenolate therapy are detrimental to hematopoietic progenitor cells. Transplantation 2002, 74, 1159-66.
84. Levsky, J.M., Shenoy, S.M., Pezo, R.C., Singer, R.H. Single-cell gene expression profiling. Science 2002, 297, 386-340.
85. Galimberti, S., Marasca, R., Caracciolo, F., Fazzi, R., Papineschi, F., Benedetti, E., Guerrini, F., Morabito, F., Oliva, E., Di Renzo, N., Federico, M., Petrini, M., Torelli, G. The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphoma. Bone Marrow Transplant. 2002, 29, 581-7.
86. Pathak, S., Multani, A.S., Furlong, C.L., Sohn, S.H. Telomere dynamics, aneuploidy, stem cells, and cancer (review). Int. J. Oncol. 2002, 20, 637-41.
87. Allsopp, R.C., Cheshier, S., Weissman, I.L. Telomerase activation and rejuvenation of telomere length in stimulated T cells derived from serially transplanted hematopoietic stem cells. J. Exp. Med. 2002, 196, 427-33.
88. Zhu, P., Li, J., Ma, M. Analysis of lymphocytic clone formation after stem cell transplantation and immunological reconstitution by gene fingerprinting Zhonghua Yi Xue Za Zhi, 80, 668-71.
89. Moore, J.E., McMullen, C.B., Mahon, G., Adamis, A.P. The corneal epithelial stem cell. DNA Cell Biol. 2002, 21, 443-51.